Table 3.
The main pharmacokinetic parameters of ambrisentan in rat plasma in two groups (n = 6).
| Parameters | Group A | Group B |
|---|---|---|
| AUC(0–t) (μg/L·h) | 41,308.92 ± 19,275.09 | 53,368.89 ± 7,683.32* |
| AUC(0–∞) (μg/L·h) | 44,893.16 ± 22,304.94 | 53,861.05 ± 7,773.54* |
| t1/2z (h) | 0.92 ± 0.42 | 0.55 ± 0.11 |
| Tmax (h) | 0.60 ± 0.55 | 0.22 ± 0.08 |
| Vz/F (L/kg) | 0.09 ± 0.06 | 0.04 ± 0.01 |
| CLz/F (L/h/kg) | 0.07 ± 0.03 | 0.05 ± 0.01 |
| Cmax (μg/L) | 31,474.53 ± 18,255.05 | 57,182.51 ± 14,900.22* |
Group A: control group; Group B: a single dose of 20 mg/kg shikonin. *p < 0.05.